Homefree is a winner of Google's Single Use Plastics Challenge
This recognition highlights Homefree's sustainability efforts. This includes offering bulk options, that reduce packaging overall, and transitioning to wrap made with 53% reworked food grade materials, diverting waste from landfills. The cookie boxes are made with local EcoVadis Platinum rated fiber (= top 1%) and printed using wind power. Homefree is a certified B Corporation, ensuring that every action is measured and evaluated quantitatively.
As Homefree continues to champion sustainability, the company invites everyone to join the movement towards a greener future. With the belief that we are all partners in change, Homefree aims to help make a lasting impact through collective efforts.
About Homefree
Homefree is a Certified Women Owned Business founded by the mother of a child with food allergies. Homefree makes inclusive baked goods in Homefree's own dedicated, Safe Quality Food (SQF) Level 3 certified facility. This includes shelf-stable mini cookies in seven flavors for retail and foodservice, with single serve, boxed and bulk options. Homefree additionally just launched a line of 1 oz. soft cookies and 2 oz. brownies delivered frozen to foodservice. All Homefree products are free from the top 14 allergens and gluten at the highest industry standard and are kosher pareve, vegan, certified a good source of whole grain, and non-GMO verified, and some are certified organic. Retail boxes can be found at select retailers, https://www.amazon.com/homefree, and AMC Theatres nationally. All products are available through foodservice.
Contact:
[email protected]
(603) 898-0172
View original content to download multimedia:https://www.prnewswire.com/news-releases/homefree-is-a-winner-of-googles-single-use-plastics-challenge-301994922.html
SOURCE Homefree, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
- Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting
- Shiba Inu Price Prediction: SHIB Bulls Target a Recovery as Remittix Approaches Its Final Presale Phase
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share